Assessment of circulating betatrophin concentrations in lean glucose-tolerant women with polycystic ovary syndrome.
The aims of the current study were to investigate the betatrophin levels in lean glucose-tolerant women with polycystic ovary syndrome (PCOS), and to explore the relationships between these levels and antropometric, hormonal and metabolic parameters. The study population consisted of 50 lean (body mass index [BMI] < 25 kg/m2) women diagnosed with PCOS using the Rotterdam criteria, and 60 age- and BMI-matched healthy controls without any features of clinical or biochemical hyperandrogenism. Before recruitment, glucose tolerance was evaluated in all of the subjects using the 2-h 75 g oral glucose-tolerance test, and only those exhibiting normal glucose tolerance were enrolled. Serum betatrophin levels were significantly higher in women with PCOS (median 322.3; range 44.7-1989.3 ng/L) compared to the controls (median 199.9; range 6.2-1912.9 ng/L; p = .005). In the control group, no significant correlation was evident between betatrophin levels and clinical or biochemical parameters. In the PCOS group, betatrophin levels were positively correlated with prolactin levels (r = .286, p = .046) and negatively correlated with BMI (r = -.283, p = .049), waist/hip ratio (r = -.324, p = .023), and low-density lipoprotein cholesterol levels (r = -.385, p = .006). Impact statement What is already known on this subject: Several studies have suggested that primary alteration in beta-cell function is a pathophysiological feature of PCOS, and insulin resistance is the most significant predictor of beta-cell dysfunction independent of obesity. Betatrophin is a circulating protein that is primarily expressed in the liver in humans. Early experimental investigations demonstrated that overexpression of betatrophin significantly promoted pancreatic beta-cell proliferation, insulin production and improved glucose tolerance. Few studies have investigated the association between PCOS and betatrophin. However, in contrast to our study, the authors included overweight/obese patients and glucose tolerance was not evaluated before recruitment. What the results of this study add: Our results showed that serum betatrophin levels were significantly higher in lean glucose-tolerant PCOS women than in age- and BMI-matched healthy controls. What are the implications of these findings for clinical practice and/or further research: Elevated betatrophin levels in PCOS women, in the absence of obesity and glucose intolerance, may reflect a compensatory mechanism in order to counteract metabolic syndrome-related risk factors.
a Department of Obstetrics and Gynecology , Antalya Training and Research Hospital , Antalya , Turkey.
Onur
O
Erol
a Department of Obstetrics and Gynecology , Antalya Training and Research Hospital , Antalya , Turkey.
Mustafa Kemal
MK
Özel
b Department of Biochemistry , Antalya Training and Research Hospital , Antalya , Turkey.
Hamit Yaşar
HY
Ellidağ
a Department of Obstetrics and Gynecology , Antalya Training and Research Hospital , Antalya , Turkey.
Tayfun
T
Toptaş
a Department of Obstetrics and Gynecology , Antalya Training and Research Hospital , Antalya , Turkey.
Aysel Uysal
AU
Derbent
b Department of Biochemistry , Antalya Training and Research Hospital , Antalya , Turkey.
Necat
N
Yılmaz
D000328:Adult; D000091306:Angiopoietin-Like Protein 8; D000075802:Angiopoietin-like Proteins / Q000097:blood*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D036361:Peptide Hormones / Q000097:blood*; D011085:Polycystic Ovary Syndrome / Q000097:blood*; D011446:Prospective Studies; D055815:Young Adult
C576683:ANGPTL8 protein, human; D000091306:Angiopoietin-Like Protein 8; D000075802:Angiopoietin-like Proteins; D036361:Peptide Hormones
Betatrophin; insulin resistance; normal glucose tolerance; polycystic ovary syndrome